Dexcom Inc (DXCM) financials

Dexcom Inc (DXCM) revenue, EBIT and EBITDA, earnings per share, free cash flow, margins, debt and shareholders equity — annual and quarterly history, charted from SEC filings. No account needed.

In fiscal 2025, Dexcom Inc reported revenue of $4.66B, up 15.6% year over year, net income of $836M, diluted EPS of $2.09 and free cash flow of $1.08B.

Revenue (fiscal 2025)

$4.66B

Revenue growth (fiscal 2025)

15.6%

Net income (fiscal 2025)

$836M

Diluted EPS (fiscal 2025)

$2.09

Free cash flow (fiscal 2025)

$1.08B

Dexcom Inc files with the U.S. Securities and Exchange Commission under CIK 0001093557, classified as Surgical & Medical Instruments & Apparatus.

Explore annual and quarterly revenue, earnings, cash flow, margins, debt and equity from SEC filings.